Repeated administration of Delta(9)-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat

Citation
J. Corchero et al., Repeated administration of Delta(9)-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat, NEUROPHARM, 38(3), 1999, pp. 433-439
Citations number
33
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROPHARMACOLOGY
ISSN journal
00283908 → ACNP
Volume
38
Issue
3
Year of publication
1999
Pages
433 - 439
Database
ISI
SICI code
0028-3908(199903)38:3<433:RAODPA>2.0.ZU;2-P
Abstract
The purpose of the present study was to explore the time related effects of repeated administration of Delta(9)-tetrahydrocannabinol on opioid and cor ticotropin releasing factor gene expression in the hypothalamus and pituita ry gland of the rat. By using in situ hybridization histochemistry, the eff ects of Delta(9)-tetrahydrocannabinol (THC, 5 mg/kg per day; i.p.) were exa mined after 1, 3, 7 and 14 days of repeated administration on; (1) proenkep halin gene expression in the paraventricular (PVN) and ventromedial nuclei (VMN) of the hypothalamus, (2) proopiomelanocortin gene expression in the a rcuate nucleus (ARC) of the hypothalamus and anterior (AL) and intermediate lobe (IL) of the pituitary gland, and (3) corticotropin releasing factor g ene expression in the PVN. The results revealed that, in most of the hypoth alamic and pituitary regions examined, repeated cannabinoid administration upregulates opioid and corticotropin releasing factor gene expression. Howe ver, the onset, the degree of magnitude of gene expression reached and the time related effects produced by repeated administration with Delta(9)-tetr ahydrocannabinol are dependent upon the brain and pituitary regions examine d. Taken together, the results of the present study suggest that cannabinoi ds produce a time related differential responsiveness in opioid and cortico tropin releasing factor gene expression, in areas of the hypothalamus and p ituitary that may be related, at least in part, to a molecular integrative response to behavioral, endocrine and neurochemical alterations that occur in cannabinoid drug abuse. (C) 1999 Elsevier Science Ltd. All rights reserv ed.